Submission Tilte
Artificial Intelligence-Driven Drug and Therapeutic Target Discovery in Alzheimer’s Disease
Submission Abstract:
Alzheimer’s Disease (AD) presents substantial biological complexity, highlighting the need for system‑level innovative strategies to advance drug and therapeutic target discovery. This Special Issue, “Artificial Intelligence-Driven Drug and Therapeutic Target Discovery in Alzheimer’s Disease,” explores the expanding role of Artificial Intelligence (AI) in transforming AD research. Featured contributions will demonstrate how AI‑based approaches deepen our understanding of disease mechanisms, enhance biomarker identification, and reveal novel therapeutic targets. The issue will encompass advances in machine learning, deep learning, network biology, multimodal data integration, and predictive modeling applied to genomics, proteomics, imaging, and clinical datasets. By integrating state‑of‑the‑art AI methodologies with biological and clinical insights, this collection aims to illustrate how AI accelerates discovery and supports the development of more precise and effective therapeutic interventions for AD.